HilleVax (HLVX) Stock Forecast & Price Target

$1.91 -0.05 (-2.55%)

(As of 12/3/2024 ET)

HilleVax - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 6 Analyst Ratings

Sell
0

Hold
6

Buy
0

Based on 6 Wall Street analysts who have issued ratings for HilleVax in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 6 have given a hold rating for HLVX.

Consensus Price Target

$3.00
57.07% Upside

According to the 6 analysts' twelve-month price targets for HilleVax, the average price target is $3.00. The highest price target for HLVX is $5.00, while the lowest price target for HLVX is $2.00. The average price target represents a forecasted upside of 57.07% from the current price of $1.91.

Get the Latest News and Ratings for HLVX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for HilleVax and its competitors.

HLVX Analyst Ratings Over Time

Type	Current Forecast 12/5/23 to 12/4/24	1 Month Ago 11/5/23 to 11/4/24	3 Months Ago 9/6/23 to 9/5/24	1 Year Ago 12/5/22 to 12/5/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	2 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$3.00	$9.20	$9.20	$32.00
Forecasted Upside	57.07% Upside	384.21% Upside	428.74% Upside	123.93% Upside
Consensus Rating	Hold	Hold	Hold	Buy

I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

HLVX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HLVX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

HilleVax Stock vs. The Competition

Type	HilleVax	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.81	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	57.07% Upside	26,615.84% Upside	7.23% Upside
News Sentiment Rating	Very Positive News See Recent HLVX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/12/2024	HC Wainwright 2 of 5 stars	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$2.00 ➝ $2.00	+25.00%
7/9/2024	Leerink Partnrs 5 of 5 stars	D. Risinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/9/2024	Leerink Partners 1 of 5 stars		Downgrade	Outperform ➝ Market Perform	$28.00 ➝ $2.00	+17.30%
7/9/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$34.00 ➝ $3.00	+82.93%
7/8/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Fernandez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
7/8/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Neutral	$24.00 ➝ $5.00	+168.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:37 AM ET.

HLVX Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for HilleVax is $3.00, with a high forecast of $5.00 and a low forecast of $2.00.
: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HilleVax in the last twelve months. There are currently 6 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLVX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLVX, but not buy additional shares or sell existing shares.
: According to analysts, HilleVax's stock has a predicted upside of 57.07% based on their 12-month stock forecasts.
: Analysts like HilleVax less than other "medical" companies. The consensus rating for HilleVax is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HLVX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

This page (NASDAQ:HLVX) was last updated on 12/4/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HilleVax (HLVX) Stock Forecast & Price Target